David Malcom Rodman - 11 Dec 2024 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role: Chief Medical Officer
Signature: /s/ Adam Levy, Attorney-in-fact
Issuer symbol: MLYS
Transactions as of: 11 Dec 2024
Net transactions value: +$2,709
Form type: 4
Filing time: 13 Dec 2024, 16:37:02 UTC
Previous filing: 12 Nov 2024
Next filing: 15 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MLYS	Common Stock	Options Exercise	$2,709	+5,017	+3.6%	$0.5400	146,008	11 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MLYS	Stock Option	Options Exercise	$0	-5,017	-50%	$0.000000	5,018	11 Dec 2024	Common Stock	5,017	$0.5400	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vested with respect to 25% of the underlying shares on March 12, 2022, and vests with respect to the remaining shares in 36 substantially equal monthly installments thereafter.